Dis-Chem's share price falls over 8% following disappointing earnings and dividend cut

Dis-Chem plans, in its 2027 financial year, to tighten the span of control of its CEO and to shift from the founder-led cross-functional leadership to a structure that creates clearer lines of accountability, with 200 new roles set to be created in underinvested departments.